Men | Women | P | |
---|---|---|---|
Coronary artery | n=54 | n=14 | |
Phenotype | |||
VH-TCFA | 16 (30) | 6 (43) | 0.60 |
VH-ThCFA | 9 (17) | 3 (21) | |
VH-PIT | 11 (20) | 1 (7) | |
VH-FC | 18 (33) | 4 (29) | |
Composition | |||
Fibrous plaque area (%) | 56 [46,65] | 52 [41,73] | 0.83 |
Fibro-fatty plaque area (%) | 16 [11,28] | 16 [11,32] | 0.98 |
Necrotic core plaque area (%) | 16 [13,23] | 14 [9,29] | 0.56 |
Dense calcium plaque area (%) | 6 [2,12] | 5 [1,10] | 0.67 |
Carotid artery | n=19 | n=10 | |
Phenotype | |||
VH-TCFA | 4 (21) | 3 (30) | 0.43 |
VH-ThCFA | 4 (21) | 2 (20) | |
VH-PIT | 4 (21) | 4 (40) | |
VH-FC | 7 (37) | 1 (10) | |
Composition | |||
Fibrous plaque area (%) | 59 [50,62] | 59 [56,69] | 0.25 |
Fibro-fatty plaque area (%) | 25 [10,37] | 18 [15,26] | 0.60 |
Necrotic core plaque area (%) | 11 [9, 20] | 15 [9, 21] | 0.48 |
Dense calcium plaque area (%) | 3 [1,7] | 2 [1,7] | 0.51 |
Renal artery | n=30 | n=20 | |
Phenotype | |||
VH-TCFA | 5 (17) | 3 (15) | 0.53 |
VH-ThCFA | 3 (10) | 0 (0) | |
VH-PIT | 17 (57) | 13 (65) | |
VH-FC | 5 (17) | 4 (20) | |
Composition | |||
Fibrous plaque area (%) | 60 [50, 68] | 59 [53, 64] | 0.71 |
Fibro-fatty plaque area (%) | 25 [14,36] | 26 [15,34] | 0.80 |
Necrotic core plaque area (%) | 6 [4,15] | 10 [4, 16] | 0.60 |
Dense calcium plaque area (%) | 3 [0, 6] | 4 [1, 9] | 0.20 |
Iliac artery | n=10 | n=4 | |
Phenotype | |||
VH-TCFA | 1 (10) | 0 (0) | 0.80 |
VH-ThCFA | 0 (0) | 0 (0) | |
VH-PIT | 4 (40) | 2 (50) | |
VH-FC | 5 (50) | 2 (50) | |
Composition | |||
Fibrous plaque area (%) | 55 [35,60] | 53 [35, 60] | 0.73 |
Fibro-fatty plaque area (%) | 20 [13,36] | 26 [9,49] | 0.84 |
Necrotic core plaque area (%) | 16 [8, 24] | 12 [10,20] | 0.64 |
Dense calcium plaque area (%) | 11 [3, 15] | 8 [6,12] | 0.84 |
VH-TCFA indicates thin-capped fibroatheroma; VH-ThCFA, thick-capped fibroatheroma; VH-PIT, pathological intimal thickening; and VH-FC, fibrocalcific plaque.